Total Flavonoids from Berberis kaschgarica Rupr. Ameliorate Atherosclerosis in ApoE−/− Mice by Regulating Lipid Metabolism and Gut Microbiota
Antioxidants · 03.06.2026 · 15 (6) · 703
DOI: 10.3390/antiox15060703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 03.06.2026. Verfasst von Adili Abudureheman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Xinjiang Medical University, Urumqi 830017, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region, Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region, Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology.
Abstract (Originalsprache)
Background
Atherosclerosis is the major pathological basis of cardiovascular diseases, while current lipid-lowering therapies remain limited by suboptimal efficacy and safety. Natural flavonoids, with their multi-target pharmacological activities, are promising candidates for anti-atherosclerotic intervention. This study investigated the protective effects and mechanisms of total flavonoids from Berberis kaschgarica Rupr. (BTF) against high-fat diet (HFD)-induced atherosclerosis in ApoE−/− mice.
Methods
Bioavailable constituents of BTF were identified by UPLC-Q-TOF-MS. Network pharmacology and bioinformatics analyses were performed to predict therapeutic targets and pathways. Male ApoE−/− mice were fed an HFD and treated with low, medium, or high doses of BTF or atorvastatin. Serum lipid profiles, oxidative stress markers, and aortic histopathology were evaluated. Hepatic proteins related to lipid metabolism were measured by Western blotting, and fecal gut microbiota were analyzed by 16S rRNA sequencing.
Results
Seven flavonoid monomers, including kaempferol, apigenin, calycosin, and dihydromyricetin, were identified as absorbed constituents in serum. Bioinformatics suggested that BTF regulates targets involved in lipid metabolism, oxidative stress, and inflammation. BTF dose-dependently decreased serum TC, TG, LDL-C, MDA, and LDH, while increasing HDL-C and the activities of SOD, GSH, and CAT. BTF also reduced atherosclerotic plaque formation and preserved aortic wall structure. Mechanistically, BTF downregulated hepatic SREBP1, ACC1, FAS, APOB, and MTP expression and improved HFD-induced gut microbiota dysbiosis by enriching Akkermansia and Lactobacillus.
Conclusions
BTF attenuated HFD-induced atherosclerosis by improving lipid metabolism, enhancing antioxidant capacity, and modulating gut microbiota composition, supporting its potential as a natural anti-atherosclerotic agent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Urumqi 830017, China.
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi 830017, China.
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi 830017, China.
ORCID-Profile: Dilihuma Dilimulati, Wenting Zhou
Förderung
- Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region
- Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education
- Natural Science Foundation for Distinguished Young Scholars of Xinjiang Uygur Autonomous Region
- Tianshan Talents—Youth Science and Technology Innovation Talents Training Program of Xinjiang Uygur Autonomous Region
Zitieren
APA
Abudureheman, A., Dilimulati, D., Paerhati, Y., Aikebaier, A., Baishan, A., Qiu, X., Yusufujiang, N., Wusiman, Y., Wumaier, A., & Zhou, W. (2026). Total Flavonoids from Berberis kaschgarica Rupr. Ameliorate Atherosclerosis in ApoE−/− Mice by Regulating Lipid Metabolism and Gut Microbiota. Antioxidants, 15(6), 703. https://doi.org/10.3390/antiox15060703
Vancouver
Abudureheman A, Dilimulati D, Paerhati Y, Aikebaier A, Baishan A, Qiu X, et al. Total Flavonoids from Berberis kaschgarica Rupr. Ameliorate Atherosclerosis in ApoE−/− Mice by Regulating Lipid Metabolism and Gut Microbiota. Antioxidants. 2026;15(6):703. doi:10.3390/antiox15060703
BibTeX
@article{Abudureheman2026,
author = {Abudureheman, Adili and Dilimulati, Dilihuma and Paerhati, Yipaerguli and Aikebaier, Alifeiye and Baishan, Alhar and Qiu, Xiaoxiao and Yusufujiang, Nazhakaiti and Wusiman, Yilixiati and Wumaier, Ainiwaer and Zhou, Wenting},
title = {Total Flavonoids from Berberis kaschgarica Rupr. Ameliorate Atherosclerosis in ApoE−/− Mice by Regulating Lipid Metabolism and Gut Microbiota},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {6},
pages = {703},
doi = {10.3390/antiox15060703}
}
EUVIMED